2.1(top 20%)
impact factor
10.6K(top 2%)
papers
241.9K(top 2%)
citations
171(top 2%)
h-index
2.2(top 20%)
impact factor
11.9K
all documents
257.0K
doc citations
247(top 2%)
g-index

Top Articles

#TitleJournalYearCitations
1Pediatric modification of the Montreal classification for inflammatory bowel diseaseInflammatory Bowel Diseases20111,182
2Long-Term Evolution of Disease Behavior of Crohn's DiseaseInflammatory Bowel Diseases20021,164
3Low counts of Faecalibacterium prausnitzii in colitis microbiotaInflammatory Bowel Diseases20091,052
4Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trendsInflammatory Bowel Diseases2011779
5Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunitiesInflammatory Bowel Diseases2006756
6Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel diseaseInflammatory Bowel Diseases2012662
7Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative ColitisInflammatory Bowel Diseases2008645
8Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS-Induced ColitisInflammatory Bowel Diseases2009611
9Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs diseaseInflammatory Bowel Diseases2009584
10Extraintestinal Manifestations of Inflammatory Bowel DiseaseInflammatory Bowel Diseases2015565
11Current Understanding of Dysbiosis in Disease in Human and Animal ModelsInflammatory Bowel Diseases2016555
12Update on the incidence and prevalence of Crohnʼs disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000Inflammatory Bowel Diseases2007549
13Consensus Conference: Colorectal Cancer Screening and Surveillance in Inflammatory Bowel DiseaseInflammatory Bowel Diseases2005530
14Intestinal barrier dysfunction in inflammatory bowel diseasesInflammatory Bowel Diseases2009506
15Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseasesInflammatory Bowel Diseases2011505
16Development of the Crohnʼs disease digestive damage score, the Lémann scoreInflammatory Bowel Diseases2011496
17Correlation of C-Reactive Protein With Clinical, Endoscopic, Histologic, and Radiographic Activity in Inflammatory Bowel DiseaseInflammatory Bowel Diseases2005488
18Depression and anxiety in inflammatory bowel disease: A review of comorbidity and managementInflammatory Bowel Diseases2009480
19Importance of disrupted intestinal barrier in inflammatory bowel diseasesInflammatory Bowel Diseases2011466
20Mechanisms of action of probiotics: Recent advancesInflammatory Bowel Diseases2009448
21Invasive potential of gut mucosa-derived fusobacterium nucleatum positively correlates with IBD status of the hostInflammatory Bowel Diseases2011437
22Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: A KASID studyInflammatory Bowel Diseases2008427
23Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor α agentsInflammatory Bowel Diseases2007423
24Magnetic resonance imaging for evaluation of Crohnʼs diseaseInflammatory Bowel Diseases2011413
25Critical role of IL-17 receptor signaling in acute TNBS-induced colitisInflammatory Bowel Diseases2006411
26Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohnʼs diseaseInflammatory Bowel Diseases2009407
27Controversies RevisitedInflammatory Bowel Diseases2016405
28C-Reactive Protein as a Marker for Inflammatory Bowel DiseaseInflammatory Bowel Diseases2004400
29Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findingsInflammatory Bowel Diseases2008397
30World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010Inflammatory Bowel Diseases2010393
31Declining Risk of Colorectal Cancer in Inflammatory Bowel DiseaseInflammatory Bowel Diseases2013391
32Infliximab in the Treatment of Severe, Steroid-Refractory Ulcerative Colitis: A Pilot StudyInflammatory Bowel Diseases2001377
33Th1/Th2 CellsInflammatory Bowel Diseases1999373
34Specificities of the fecal microbiota in inflammatory bowel diseaseInflammatory Bowel Diseases2006373
35Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases#Inflammatory Bowel Diseases2007373
36Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel diseaseInflammatory Bowel Diseases2006371
37NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasisInflammatory Bowel Diseases2011366
38Antitumor Necrosis Factor Therapy for Inflammatory Bowel Disease: A Review of Agents, Pharmacology, Clinical Results, and SafetyInflammatory Bowel Diseases1999356
39Changes in Clinical Characteristics, Course, and Prognosis of Inflammatory Bowel Disease during the Last 5 Decades: A Population-Based Study from Copenhagen, DenmarkInflammatory Bowel Diseases2007340
40Molecular diversity of Escherichia coli in the human gut: New ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohnʼs diseaseInflammatory Bowel Diseases2009339
41Dietary Risk Factors for Inflammatory Bowel DiseaseInflammatory Bowel Diseases2005338
42Il-6 signaling in inflammatory bowel disease: Pathophysiological role and clinical relevanceInflammatory Bowel Diseases2007336
43Lactobacillus plantarum 299V in the Treatment and Prevention of Spontaneous Colitis in Interleukin-10-Deficient MiceInflammatory Bowel Diseases2002325
44Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohnʼs Disease, and PouchitisInflammatory Bowel Diseases2014320
45Dysbiosis of fecal microbiota in Crohnʼs disease patients as revealed by a custom phylogenetic microarrayInflammatory Bowel Diseases2010314
46A Randomized, Double-blind Trial of Lactobacillus GG Versus Placebo in Addition to Standard Maintenance Therapy for Children with Crohnʼs DiseaseInflammatory Bowel Diseases2005303
47A Randomized Clinical Trial of Ciprofloxacin and Metronidazole to Treat Acute PouchitisInflammatory Bowel Diseases2001300
48Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohnʼs disease and analysis of the IL17F p.His161Arg polymorphism in IBDInflammatory Bowel Diseases2008291
49Both IL-12p70 and IL-23 are synthesized during active Crohnʼs disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibodyInflammatory Bowel Diseases2006290
50Intestinal Inflammation and Mucosal Barrier FunctionInflammatory Bowel Diseases2014287